Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany

Veterinary Infectious Virus Antigens

Overview

Veterinary infectious disease virus is the main factors affecting the health of livestock, domestic animals and wild animals. Due to deforestation and biodiversity loss associated with the expansion of agricultural land, animal breeding may indirectly lead to the spread of wild animal pathogens. In addition, intensive animal farming has created conditions for the emergence and expansion of epidemics.

Emerging Diseases Affecting Various Animal SpeciesFig. 1 Emerging Diseases Affecting Various Animal Species (Roth JA. 2011)

The COVID-19 pandemic shows that the social costs caused by animal infectious diseases could be huge. They include not only the direct human and animal health costs, but also the indirect economic costs of reducing business activities, as well as the related environmental impacts during and after the epidemic, and the costs of preventive measures. The effective control of these infectious diseases is essential to social economy, food safety and security, and human health. The research of veterinary infectious disease virus includes pathogen, epidemiology, diagnostic methods, molecular evolution, immune response, treatment and prevention of infectious diseases.

The general veterinary diagnostic methods to veterinarians, the livestock industry, and researchers include:

  • Virus isolation is a highly sensitive detection method, which can provide materials for further drug research. However, it is usually time-consuming, difficult and expensive, and is ineffective for non-viable viruses or non-cultivable agents.
  • Serological identification of viruses or antigens (e.g. enzyme-linked immunosorbent assay, ELISA) is not applicable to all viruses. However, it is fast, sensitive and can provide information on virus serotype. There are many commercial diagnostic kits available.
  • Polymerase chain reaction (PCR) can detect the viral genome, which is fast and sensitive, but high sensitivity can lead to the detection of unrelated co-infection. It can be applicable to all viruses, including non-culturable viruses.

The burden of veterinary infectious diseases is a major constraint to sustainable agricultural development, food security and participation of developing countries in international trade of livestock products. Vaccination is one of the most important and cost-effective methods to prevent veterinary infectious diseases. Most licensed viral vaccines are live-attenuated and inactivated. Live-attenuated vaccine is very effective in inducing long-term immunity through cell-mediated and humoral immune response. However, these vaccines are not suitable for pregnant and immunocompromised animals, and some have the potential to return to virulence. Inactivated vaccines are not able to self-replicate, so they cannot infect other identities, but they lack the ability to induce lasting and comprehensive cell-mediated immune responses. Recombinant subunits, DNA and non-pathogenic virus-free vaccines are the most cost-effective methods for antigen production. These antigens do not contain exogenous substances related to conventional vaccines, toxins related to pathogens and immunosuppressive components, and have the ability to trigger long-term immunity.

References

  1. Espinosa R, et al. (2020). "Infectious Diseases and Meat Production." Environmental and Resource Economics 76(4), 1019-1044.
  2. Tomley FM, Shirley MW. (2009). "Livestock infectious diseases and zoonoses." Philosophical Transactions of the Royal Society B Biological Sciences 364(1530), 2637-42.
  3. Roth JA. (2011). "Veterinary Vaccines and Their Importance to Animal Health and Public Health." Procedia in Vaccinology 5, 127-136.
  4. Burrell CJ, et al. (2017). Laboratory Diagnosis of Virus Diseases. Fenner and White's Medical Virology, 135–54.
  5. Lubroth J, et al. (2007). Veterinary vaccines and their use in developing countries. Revue Scientifique et Technique 26(1), 179-201.
<
Cat. No.Product NameExpression SystemInquiry
DAG-WT806Recombinant PRRSV N-NSP7 Fusion AntigenE. coliInquiry    
DAG-WT1118Recombinant Porcine Circovirus Type 3 Capsid ProteinE. coliInquiry    
DAG-WT1128Recombinant Porcine Circovirus Type 2 Capsid ProteinMammalian cellsInquiry    
DAG-WT1119Recombinant Transmissible Gastroenteritis Virus N ProteinE. coliInquiry    
DAG-WT1123Recombinant Pseudorabies Virus gBMammalian cellsInquiry    
DAG-WT1124Recombinant Pseudorabies Virus gEMammalian cellsInquiry    
DAG-WT1125Recombinant Pseudorabies Virus Chimeric Protein (gE&gl)Mammalian cellsInquiry    
DAG-WT1131Inactivated Pseudorabies Virus (PRV)-Inquiry    
DAG-WT1129Inactivated Porcine Epidemic Diarrhea Virus Antigen-Inquiry    
DAG-WT1130Inactivated Seneca Valley virus (SVV)-Inquiry    
DAG-WT1132Inactivated Classical Swine Fever Virus (CSFV)-Inquiry    
DAG-WT1126Recombinant Bovine Viral Diarrhea Virus (BVDV) E2 ProteinMammalian cellsInquiry    
DAG-WT1136Inactivated Bovine Viral Diarrhea Virus (BVDV)-Inquiry    
DAG-WT1127Recombinant Bovine Rhinotracheitis Virus Glycoprotein DMammalian cellsInquiry    
DAG-WT1120Recombinant Newcastle Disease Virus F ProteinMammalian cellsInquiry    
DAG-WT1121Recombinant Infectious Bronchitis Virus N ProteinE. coliInquiry    
DAG-WT1122Recombinant Avian Leukosis Virus p27E. coliInquiry    
DAG-WT1133Inactivated Chicken Infectious Anemia Virus (CIAV)-Inquiry    
DAG-WT1134Inactivated Anatid alphaherpesvirus 1(AnHV-1)-Inquiry    
DAG-WT1113Recombinant Feline Herpesvirus 1 gD [His]Mammalian cellsInquiry    
DAG-WT1114Recombinant Feline Leukemia Virus P27 [His]Mammalian cellsInquiry    
DAG-WT1135Inactivated Feline Herpes Virus (FHV)-Inquiry    
Inquiry Basket
loading Loading ......

Inquiry

Inquiry